Background: Trisomy 21 or Down syndrome (DS) is the most common aneuploidy disorder. Fetal karyotypic analysis remains the criterion standard for prenatal diagnosis of DS, although the method is time consuming and requires skilled personnel. Real-time quantitative polymerase chain reaction (qPCR) can be used to determine a difference in the amount of gene copy by calculation of the difference between the cycle threshold (ΔC
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Down syndrome (DS) is the most common genetic condition occurring approximately in one of 800 live births [1] . Patients with DS have cognitive impairment and complications from anomalies of several organ systems [2, 3] . Trisomy 21 is the most common abnormal karyotype found in 95% of patients [4] .
Prenatal diagnosis is generally offered for pregnant women who are at high risk of having an offspring with DS [5] . Until recently, a definite prenatal diagnosis of DS is usually made by a conventional cytogenetic analysis of fetal-derived cells from chorionic villi or amniotic fluid. Although the method yields highly accurate results and also can detect other numerical chromosomal aberrations, it requires a cell culture process and therefore is laborious and timeconsuming.
Several methods in molecular genetics, such as interphase fluorescent in situ hybridization (FISH) and quantitative fluorescence polymerase chain reaction (QF-PCR) have been developed to overcome the disadvantages of the cytogenetic analysis [6] [7] [8] [9] [10] . Because these methods do not require a cell culture, they provide a more rapid diagnosis. The methods have been applied for prenatal diagnosis of common chromosomal disorders including trisomy 13, 18, and 21. Recently, chromosomal microarray analysis has also been reported [11] . Although interphase FISH, QF-PCR, and chromosomal microarray analysis provide shorter turnaround laboratory time than conventional cytogenetic analysis, the methods are not commonly available and their costs are high.
Real-time quantitative PCR (qPCR) has been used to detect an alteration in the gene copy number, by using the difference in cycle threshold (ΔC T ). C T is a cycle number of PCR required before the amplified product is detected. A lower C T number implies that there are more DNA templates at the beginning of the reaction. ΔCT between an amplification of two genes from the same DNA templates in the same reaction indicates that the copy numbers of the genes are different.
Zimmermann et al. developed a qPCR method to diagnose trisomy 21 by coamplification of an amyloid gene on chromosome 21 and a glyceraldehydes 3-phosphate dehydrogenase (GADPH) gene on chromosome 12 as a control. The method could correctly diagnose nine out of ten cases of trisomy 21 and nine out of eleven cases with a normal karyotype [12] . There are later successful reports of using qPCR for diagnosis of trisomy 21 [13, 14] . However, one study shows conflicting results [15] .
In this study, we aimed to develop a qPCR method for a diagnosis of trisomy 21. C T was used to estimate the relative amount of the short tandem repeat (STR) locus D21S11 on chromosome 21 and the DNA fragment within an α-globin gene cluster (designated SM). The SM fragment is located within an α-globin gene cluster, approximately 10 kilobases 5′ to α-globin 2 gene (HBA2). The DNA fragment is used as a reference marker because of its good consistency for amplification by PCR in our laboratory and that it is not in the region that is deleted in common α-thalassemia. We used ΔC [16] . Because changes of the C T are associated with exponential change of the amplified PCR product, it is suggested that the 2 -CT value may be used to determine the relative amount of a gene compared to a reference gene. The value in trisomy 21 is postulated to be 1.5 while in a normal sample is 1.0.
Materials and methods
Our institutional ethics committee approved the study protocol. Ten children who attended the Genetic clinic at Chiang Mai University Hospital, Chiang Mai, Thailand, who had trisomy 21 as previously confirmed by conventional cytogenetic analysis, were included. Their parents were included as controls. Informed consent was obtained from the parents.
Detailed history taking and physical examination of all parents was performed to exclude chromosome disorders. Four milliliters of blood sample in EDTA was collected from each subject. Genomic DNA was extracted from leukocytes by using a QIAamp DNA Blood Mini kit (Qiagen, Hilden, Germany) as per the manufacturer's protocols. , and 1.5 μmol/L of SYTO9 dye, in 1× PCR buffer. The PCR cycles consisted of a 2 minutes initial denaturation followed by 44 cycles of 95°C for 15 seconds, 60°C for 15 seconds, and 72°C for 15 seconds on a Bio-Rad Real time thermal cycler CFX96 (Bio-Rad Laboratories, Hercules, CA, USA). The PCR protocol was modified from a method previously described by Pornprasert et al. [17] . The reactions were performed in duplicate and the C T value of each PCR was measured automatically. The average C T value was used for calculation. Standard curves for D21S11 and SM were established by using serial dilutions of genomic DNA.
For statistical analysis, we discriminated the specimens into two groups, which were patients and controls (fathers and mothers of patients). The ΔC -ΔΔCT values between patients and their parents. P < 0.05 was considered statistically significant.
Results
The standard curves for D21S11 and SM were shown in Figure 1 . The PCR amplification efficiencies were 92.1% for D21S11 and 93.7% for SM. There was a high linear correlation between the C T and log value of the DNA concentration.
The calculated D21S11/SM ΔC T values of each individual and 2
-ΔΔCT values between the patients and their parents were analyzed with SPSS Version 12. The result showed ΔC T from the DS group were higher than the control group except for one family. The mean ΔC T from DS group, father and mother were 4.21 ± 0.61, 3.37 ± 0.49, and 3.46 ± 0.77 respectively. The differences were significant both between the DS and father group (95% CI 0.29-1.38, P = 0.007) and between the DS and mother group (95% CI 0.24-1.27, P = 0.009).
The mean 2 -ΔΔCT values between patients and mothers was 1.88 ± 0.95 (95% CI 1.20-2.56), and between fathers and mothers as controls was 1.06 ± 0.68 (95% CI 0.58-1.54).
Discussion
Rapid diagnosis of DS is needed in the setting of prenatal diagnosis, especially when couples present later in the second trimester. In this study, a qPCR to detect relative gene copy ratio of D21S11 STR locus on chromosome 21 and SM fragment on chromosome 16 as a control was established. Theoretically, by using the 2
-ΔΔCT values of D21S11/SM gene, which reflects the relative gene copy of D21S11, the relative copy number of D21S11 in trisomy 21 should be 1.5. From this study, the 2 -ΔΔCT mean value of D21S11/SM gene in the DS group was 1.88 ± 0.95, while in controls the value was 1.06 ± 0.68. The values were higher than 1.5 and 1.0 which may be explained by different amplification efficiencies of D21S11 and SM. The qPCR test can correctly diagnose nine of ten trisomy 21 patients. Helmy et al. also reported the use of DSCR3/ GAPDH ratio to diagnose trisomy 21 [15] . However, the ratio between the trisomy 21 and control groups (7 DS patients and five controls, and three DS fetuses and 18 normal controls) were not found to be different, although the amplification efficiencies of both genes were similar. The authors recommended further studies before the tests may be routinely used.
The current study demonstrates that the detection of gene copy difference by qPCR is a promising method for the diagnosis of trisomy 21. The method is rapid and feasible to set up in most laboratories. However, with the occurrence of false negative results, controls within each batch of a study are important. Further studies in larger population, and using of more than one index loci on chromosome 21 to decrease false negative results is suggested.
Conclusion
This study shows that using 2 -ΔΔCT values of D21S11/SM gene to determine relative gene copy of D21S11 is feasible for the diagnosis of trisomy 21, although false negative results may occur. Further studies with an addition of more than one index gene on chromosome 21 are suggested to consolidate the method. It can also be applied for diagnosis of other aneuploidy syndromes, such as trisomy 13 or 18.
